BRAF and central nervous system cancer: BRAF V600 mutations have been identified in several adult glioma subtypes, including PXAs, gangliogliomas, anaplastic gangliogliomas, PAs, and, more rarely, adult HGGs (aHGGs) including GBM, with an overall incidence of 4% (153).